EUVIMEDEUVIMED entdecken
Open Access

COVID-19 and Rates of Cancer Diagnosis in the US

Todd Burus, Feitong Lei, Bin Huang, W Jay Christian, Pamela C Hull, Amanda R Ellis, Svetla Slavova, Thomas C Tucker, Krystle A Lang Kuhs

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2024.32288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Todd Burus und 8 weiteren Autor:innen. Beteiligte Einrichtung: Markey Cancer Center, University of Kentucky, Lexington. Hauptthemen laut MEDLINE: COVID-19, Neoplasms, SEER Program. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance US cancer diagnoses were substantially lower than expected during the COVID-19 pandemic in 2020. A national study on the extent to which rates recovered in 2021 has not yet been conducted.

Objective

To examine observed vs expected cancer rate trends for January 2020 to December 2021. Design, Setting, and Participants This cross-sectional, population-based study of cancer incidence trends used the Surveillance, Epidemiology, and End Results 22 (SEER-22) Registries Database, which covers 47.9% of the US population. Included individuals were those with an invasive cancer diagnosis reported to registries included in SEER-22 between January 1, 2000, and December 31, 2021. Exposures Age, sex, race and ethnicity, urbanicity, and stage at diagnosis. Main Outcomes and Measures Expected cancer incidence rates were measured for the COVID-19 pandemic years of 2020 and 2021 from prepandemic trends using ensemble forecasting methods. Relative difference between observed and expected cancer incidence rates and numbers of potentially missed cases were measured.

Results

The SEER-22 registries reported 1 578 697 cancer cases in 2020 and 2021, including 798 765 among male individuals (50.6%) and 909 654 among persons aged 65 years or older (57.6%). Observed all-sites cancer incidence rates were lower than expected by 9.4% in 2020 (95% prediction interval [PI], 8.5%-10.5%), lower than expected by 2.7% in 2021 (95% PI, 1.4%-3.9%), and lower than expected by 6.0% across both years combined (95% PI, 5.1%-7.1%), resulting in 149 577 potentially undiagnosed cancer cases (95% PI, 126 059-176 970). Of the 4 screening-detected cancers, only female breast cancer showed significant recovery in 2021, exceeding expected rates by 2.5% (95% PI, 0.1%-4.8%), while significant reductions remained for lung cancer (9.1% lower than expected; 95% PI, 6.4%-13.2%) and cervical cancer (4.5% lower than expected; 95% PI, 0.4%-8.0%), particularly for early stage at diagnosis. Rates of all-sites cancer incidence returned to prepandemic trends in 2021 among female individuals, persons aged younger than 65 years, and persons of non-Hispanic Asian and Pacific Islander race and ethnicity. Conclusions and Relevance This population-based cross-sectional study of US cancer incidence trends found that rates of diagnosis improved in 2021 but continued to be lower than expected, adding to the existing deficit of diagnosed cases from 2020. Particular attention should be directed at strategies to immediately increase cancer screenings to make up lost ground.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsSEER ProgramHumansFemaleUnited StatesMaleIncidenceAgedMiddle AgedCross-Sectional StudiesAdultSARS-CoV-2PandemicsAged, 80 and overAdolescentRegistriesYoung Adult

Autor:innen und Institutionen

  • Markey Cancer Center, University of Kentucky, Lexington.
  • Division of Cancer Biostatistics, College of Medicine, University of Kentucky, Lexington.
  • Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington.
  • Department of Epidemiology & Environmental Health, College of Public Health, University of Kentucky, Lexington.
  • Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington.
  • Department of Biostatistics, College of Public Health, University of Kentucky, Lexington.

Förderung

  • NCI NIH HHS

Zitieren

APA

Burus, T., Lei, F., Huang, B., Christian, W. J., Hull, P. C., Ellis, A. R., Slavova, S., Tucker, T. C., & Lang Kuhs, K. A. (2024). COVID-19 and Rates of Cancer Diagnosis in the US. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.32288

Vancouver

Burus T, Lei F, Huang B, Christian WJ, Hull PC, Ellis AR, et al. COVID-19 and Rates of Cancer Diagnosis in the US. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.32288

BibTeX
@article{Burus2024,
  author = {Burus, Todd and Lei, Feitong and Huang, Bin and Christian, W Jay and Hull, Pamela C and Ellis, Amanda R and Slavova, Svetla and Tucker, Thomas C and Lang Kuhs, Krystle A},
  title = {COVID-19 and Rates of Cancer Diagnosis in the US},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2024.32288}
}
Kostenlos starten →